| For: | Kang YB, Cai Y. Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer. World J Gastroenterol 2021; 27(32): 5362-5375 [PMID: 34539138 DOI: 10.3748/wjg.v27.i32.5362] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i32/5362.htm |
| Number | Citing Articles |
| 1 |
Dong-Dong Ti, Peng Liu, Chun-Yan Wu, Zhi-Ming Shi, Shu-Ming Guo, Zhan-Cheng Gao. Host and gut microbiota crosstalk: A new paradigm for colorectal cancer immunotherapy. World Journal of Clinical Oncology 2026; 17(4): 118606 doi: 10.5306/wjco.v17.i4.118606
|
| 2 |
Elena Layunta, Berta Buey, Jose Emilio Mesonero, Eva Latorre. Crosstalk Between Intestinal Serotonergic System and Pattern Recognition Receptors on the Microbiota–Gut–Brain Axis. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.748254
|
| 3 |
Ishfaq Hassan Mir, Saqib Hassan, Joseph Selvin, Chinnasamy Thirunavukkarasu. Human Microbiome in Health, Disease, and Therapy. 2023; doi: 10.1007/978-981-99-5114-7_7
|
| 4 |
Rashmi Bhushan, Md. Abubakar, Pavan Ramrao Chavan, Ruchi Pandey, Mohini Santosh Jamadade, Krishna Murti, Nitesh Kumar. Chemoresistance in Glioblastoma. 2026; doi: 10.1016/B978-0-443-33910-3.00005-4
|
| 5 |
Andrea L. Cote, Chad J. Munger, Alison E. Ringel. Emerging insights into the impact of systemic metabolic changes on tumor-immune interactions. Cell Reports 2025; 44(2) doi: 10.1016/j.celrep.2025.115234
|
| 6 |
Shanshan Yang, Suya Zhao, Yixiang Ye, Liqun Jia, Yanni Lou. Global research trends on the links between gut microbiota and cancer immunotherapy: A bibliometric analysis (2012-2021). Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.952546
|
| 7 |
Christopher J. M. Williams, Allyson M. Peddle, Pashtoon M. Kasi, Jenny F. Seligmann, Campbell S. Roxburgh, Gary W. Middleton, Sabine Tejpar. Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response. Nature Reviews Clinical Oncology 2024; 21(12) doi: 10.1038/s41571-024-00943-6
|
| 8 |
Yuqing Zhou, Zhaoxia Liu, Tingtao Chen. Gut Microbiota: A Promising Milestone in Enhancing the Efficacy of PD1/PD-L1 Blockade Therapy. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.847350
|
| 9 |
Made William Suarta, Lara Souza Lemos , Giorgia Bergamasco Perini , Aline Gabriele Etur Dos Santos, Michael Rubens Ling Saue Chan. REVISÃO DE LITERATURA ACERCA DO TRANSPLANTE FECAL COMO ESTRATÉGIA TERAPÊUTICA EM PACIENTES COM CÂNCER GASTROINTESTINAL. Brazilian Medical Students 2025; 10(14) doi: 10.53843/bms.v9i13.560
|
| 10 |
Sumon Giri, Zainab Irfan, Sayed Mohammed Firdous. Emerging Strategies in Cancer Metabolism. 2026; doi: 10.1016/B978-0-443-33459-7.00010-7
|
| 11 |
Masakazu Murayama, Masahiro Hosonuma, Atsuo Kuramasu, Kiyoshi Yoshimura. Current Status of Immune Checkpoint Inhibitors in the Broncho-Esophagological Field. Nihon Kikan Shokudoka Gakkai Kaiho 2022; 73(5) doi: 10.2468/jbes.73.308
|
| 12 |
Mamali Das, Chandramohan Kiruthiga, R. Beema Shafreen, Kathiresan Nachammai, Chandrabose Selvaraj, K. Langeswaran. Harnessing the human microbiome and its impact on immuno-oncology and nanotechnology for next-generation cancer therapies. European Journal of Pharmacology 2025; 996 doi: 10.1016/j.ejphar.2025.177436
|
| 13 |
Durlav Chowdhury, Ashmita Das, Mrityunjay Mishra, Trinkal Khutere, Surendra H. Bodakhe. Physiological markers for immunotherapeutics: a review. Journal of Chemotherapy 2025; 37(8) doi: 10.1080/1120009X.2024.2443701
|
| 14 |
Qinhan Cao, Meiju Yang, Min Chen. Metabolic interactions: how gut microbial metabolites influence colorectal cancer. Frontiers in Microbiology 2025; 16 doi: 10.3389/fmicb.2025.1611698
|
| 15 |
Yongbo Kang, Liping Li, Xing Kang, Yanqin Zhao, Yue Cai. Gut microbiota and metabolites in myasthenia gravis: Early diagnostic biomarkers and therapeutic strategies. Clinical Immunology 2022; 245 doi: 10.1016/j.clim.2022.109173
|
| 16 |
Naoko Ohtani, Tomonori Kamiya, Norifumi Kawada. Recent updates on the role of the gut-liver axis in the pathogenesis of NAFLD/NASH, HCC, and beyond. Hepatology Communications 2023; 7(9) doi: 10.1097/HC9.0000000000000241
|
| 17 |
Pengya Feng, Xia Xue, Ihtisham Bukhari, Chunjing Qiu, Yingying Li, Pengyuan Zheng, Yang Mi. Gut microbiota and its therapeutic implications in tumor microenvironment interactions. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1287077
|
| 18 |
Durre Aden, Samreen Zaheer, Nuruddin Mohammad Iqbal, Sufian Zaheer. Gut microbiota and cancer therapy: mechanisms, challenges, and opportunities. MGM Journal of Medical Sciences 2026; 13(3) doi: 10.4103/mgmj.mgmj_82_26
|
| 19 |
Min Deng, Xiaoyu Li, Huiming Wu, Dingwen Xue, Yize Wang, Renkai Guo, Yipeng Cui, Chenfei Jin, Fei luo, Huiyu Li. The current status and prospects of gut microbiota combined with PD-1/PD-L1 inhibitors in the treatment of colorectal cancer: a review. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03968-y
|
| 20 |
Yongbo Kang, Yue Cai. Commentary: Boosting Vaccine-Elicited Respiratory Mucosal and Systemic COVID-19 Immunity in Mice With the Oral Lactobacillus plantarum. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.846379
|
| 21 |
Aswathi Ramesh, Rajasekaran Subbarayan, Rupendra Shrestha, Pooja Narain Adtani. Exploring Fecal Microbiota Transplantation: Potential Benefits, Associated Risks, and Challenges in Cancer Treatment. Cancer Reports 2026; 9(1) doi: 10.1002/cnr2.70455
|
| 22 |
Aaron Varghese, Suzanne M. Hess, Shanmuga Chilakapati, Jose R. Conejo-Garcia, A.J. Robert McGray, Emese Zsiros. Tertiary lymphoid structures: exploring opportunities to improve immunotherapy in ovarian cancer. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1473969
|
| 23 |
Yang He, Wendong Gu, Yingjie Shao. Research progress on immunotherapy combined with neoadjuvant concurrent chemoradiotherapy in pMMR/MSS locally advanced rectal cancer. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1631620
|
| 24 |
Andreea Laura Antohi, Andreea Daria Gheorghiță, Octavian Andronic, Gratiela Gradisteanu Pircalabioru, Andreea-Ramona Treteanu. Across the Social Network of the Gut: Bacterial, Fungal, and Viral Determinants of Checkpoint Inhibitor Efficacy and Toxicity. International Journal of Molecular Sciences 2026; 27(6) doi: 10.3390/ijms27062538
|
| 25 |
Yongbo Kang, Yue Cai, Yanqin Zhao, Ying Yang. The gut microbiome and Alopecia areata: Implications for early diagnostic biomarkers and novel therapies. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.979876
|
| 26 |
Victor Uchenna Chigozie, Charles Okechukwu Esimone. Engineering microbial metabolites to modulate tumor immunity and advance cancer immunotherapy. Discover Immunity 2026; 3(1) doi: 10.1007/s44368-026-00019-w
|
| 27 |
Kostas A. Papavassiliou, Amalia A. Sofianidi, Fotios G. Spiliopoulos, Angeliki Margoni, Athanasios G. Papavassiliou. Emerging Issues Regarding the Effects of the Microbiome on Lung Cancer Immunotherapy. Biomolecules 2025; 15(11) doi: 10.3390/biom15111525
|
| 28 |
Jinglong Huang, Caifeng Gong, Aiping Zhou. Modulation of gut microbiota: a novel approach to enhancing the effects of immune checkpoint inhibitors. Therapeutic Advances in Medical Oncology 2023; 15 doi: 10.1177/17588359231204854
|
| 29 |
Alexander Biederstädt, Katayoun Rezvani. Engineered natural killer cells for cancer therapy. Cancer Cell 2025; 43(11) doi: 10.1016/j.ccell.2025.09.013
|
| 30 |
Sheema Khan, Goutam Banerjee, Saini Setua, Daleniece Higgins Jones, Bhavin V. Chauhan, Anupam Dhasmana, Pratik Banerjee, Murali Mohan Yallapu, Stephen Behrman, Subhash C. Chauhan. Metagenomic analysis unveils the microbial landscape of pancreatic tumors. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1275374
|
| 31 |
Maude Jans, Lars Vereecke. A guide to germ‐free and gnotobiotic mouse technology to study health and disease. The FEBS Journal 2025; 292(6) doi: 10.1111/febs.17124
|
| 32 |
Jhommara Bautista, Andrés López-Cortés. The hallmarks of host-microbiome decoupling. Frontiers in Microbiology 2026; 17 doi: 10.3389/fmicb.2026.1801100
|
| 33 |
Yong-Bo Kang, Yue Cai. Future prospect of “Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients”. World Journal of Gastroenterology 2022; 28(20): 2248-2250 doi: 10.3748/wjg.v28.i20.2248
|
| 34 |
Esther Ugo Alum, Daniel Ejim Uti, Okechukwu Paul-Chima Ugwu, Benedict Nnachi Alum, Friday Ogbu Edeh, Christine Ainebyoona. Unveiling the microbial orchestra: exploring the role of microbiota in cancer development and treatment. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02352-2
|
| 35 |
Sandeep K Mundhra, Rakesh Kochhar. Methodological insights into fecal microbiota transplantation: Dissecting key approaches for success. World Journal of Methodology 2026; 16(1): 108875 doi: 10.5662/wjm.v16.i1.108875
|
| 36 |
. 2023; doi: 10.70675/f5302927z1f86z40e0z8c9czdde5ffdd2d7a
|
| 37 |
Reza Bayat Mokhtari, Manpreet Sambi, Faezeh Shekari, Kosar Satari, Roya Ghafoury, Neda Ashayeri, Paige Eversole, Narges Baluch, William W. Harless, Lucia Anna Muscarella, Herman Yeger, Bikul Das, Myron R. Szewczuk, Sayan Chakraborty. A Comprehensive Oncological Biomarker Framework Guiding Precision Medicine. Biomolecules 2025; 15(9) doi: 10.3390/biom15091304
|
| 38 |
Yongbo Kang, Yue Cai, Ying Yang. The Gut Microbiome and Hepatocellular Carcinoma: Implications for Early Diagnostic Biomarkers and Novel Therapies. Liver Cancer 2022; 11(2) doi: 10.1159/000521358
|
| 39 |
Matthew Dietz, Travis J. Gates, Rakesh Sikdar, Subbaya Subramanian, Mikael H. Elias, Christopher Staley. Impeding Quorum Sensing Among the Intestinal Microbiota Impacts the Metastatic Rate of Colorectal Cancer. Cancer Medicine 2025; 14(12) doi: 10.1002/cam4.71009
|
| 40 |
Tiziana Vescovo, Giulio Bontempi, Mohammadreza Bayat, Lucia Piredda, Marco Fidaleo, Raffaele Strippoli, Manuela Antonioli. Gut microbiota interplay with autophagy-EMT dynamics in colorectal cancer. Frontiers in Cell and Developmental Biology 2025; 13 doi: 10.3389/fcell.2025.1608248
|
| 41 |
Shanshan Yang, Shaodong Hao, Hui Ye, Xuezhi Zhang. Global research on the crosstalk between intestinal microbiome and colorectal cancer: A visualization analysis. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1083987
|
| 42 |
Mei Liu, Ying Hu, Meng-Dai Xu, Yi Chen, Qing-Bin Meng. Therapeutic potential and clinical advances of fecal microbiota transplantation in disease management. Food & Medicine Homology 2027; 4(1) doi: 10.26599/FMH.2027.9420146
|